DHHS, National Institute on Drug Abuse, Contracts Management Branch, OPRM, Parklawn Building, Room 10-49, 5600 Fishers Lane, Rockville, Maryland 20857

A -- IN VITRO HIGH CAPACITY SCREENING FOR COCAINE TREATMENT MEDICATIONS DEVELOPMENT SOL N01DA-6-8070 DUE 061496 POC Point of Contact, Kenneth E. Goodling, Contracting Officer, Phone: (301) 443-6677 The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to perform automated (robotic) high capacity screening of in vitro dopamine transporter binding and uptake inhibition assays. Proprietary test compounds will be evaluated in established assays, and the resulting data will be utilized by the Cocaine Treatment Discovery Program of the NIDA Medications Development Division. Offerors must indicate possession of current DEA registration for Schedule II-V substances and have applied for Schedule I registration prior to award. It is estimated that a 2 year contract, with additional quantity options, will result from this procurement. Estimated issuance date of RFP No. N01DA-6-8070 is April 30, 1996, and responses are due to be received in the Contracting Office 45 calendar days thereafter. Written requests for copies of the solicitation will be honored if received within thirty calendar days after issuance of the solicitation. Written requests received after this period will be filled on a first-come, first-served basis until the the supply is exhausted; however, there is no assurance that copies requested after the thirtieth day will reach the requestor before the due date for receipt of responses. Written requests shall be forwarded to the Contracting Officer. (0096)

Loren Data Corp. http://www.ld.com (SYN# 0006 19960408\A-0006.SOL)